降钙素原能否有效区分脓毒症与非感染性全身炎症反应综合征

[1] 生物标志物组合对急诊脓毒症和重度脓毒症患者的诊断价值[J] 赵永祯;李春盛; 中华危重病急救医学 2014, 03

[2] 降钙素原动态监测对肝移植术后感染并发症的诊断价值 [J]. 中华内科杂志, 2009, (05)

[3] Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis[J] Christina Wacker;Anna Prkno;Frank M Brunkhorst;Peter Schlattmann The Lancet Infectious Diseases 2013,

[4] Procalcitonin neutralizes bacterial LPS and reduces LPS-induced cytokine release in human peripheral blood mononuclear cells.[J] Matera Giovanni;Quirino Angela;Giancotti Aida;Pulicari Maria Concetta;Rametti Linda;Rodríguez Maria Luz;Liberto Maria Carla;Focà Alfredo BMC microbiology 2012,

[5] Biomarkers in the Critically Ill Patient: Procalcitonin[J] Konrad Reinhart;Michael Meisner Critical Care Clinics 2011,

[6] Deaths: preliminary data for 2008.[J] Miniño Arialdi M;Xu Jiaquan;Kochanek Kenneth D National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System 2010,

[7] Sepsis biomarkers: a review.[J] Pierrakos Charalampos;Vincent Jean-Louis Critical care (London, England) 2010,

[8] Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis: a prospective study.[J] Brodska Helena;Drabek Tomas;Malickova Karin;Kazda Antonin;Vitek Antonin;Zima Tomas;Markova Marketa Critical care (London, England) 2009,

[9] Induction of procalcitonin in liver transplant patients treated with anti-thymocyte globulin.[J] Zazula Roman;Prucha Miroslav;Tyll Tomas;Kieslichova Eva Critical care (London, England) 2007,

[10] Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis[J] Benjamin MP Tang;Guy D Eslick;Jonathan C Craig;Anthony S McLean The Lancet Infectious Diseases 2007,

[1] 生物标志物组合对急诊脓毒症和重度脓毒症患者的诊断价值[J] 赵永祯;李春盛; 中华危重病急救医学 2014, 03

[2] 降钙素原动态监测对肝移植术后感染并发症的诊断价值 [J]. 中华内科杂志, 2009, (05)

[3] Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis[J] Christina Wacker;Anna Prkno;Frank M Brunkhorst;Peter Schlattmann The Lancet Infectious Diseases 2013,

[4] Procalcitonin neutralizes bacterial LPS and reduces LPS-induced cytokine release in human peripheral blood mononuclear cells.[J] Matera Giovanni;Quirino Angela;Giancotti Aida;Pulicari Maria Concetta;Rametti Linda;Rodríguez Maria Luz;Liberto Maria Carla;Focà Alfredo BMC microbiology 2012,

[5] Biomarkers in the Critically Ill Patient: Procalcitonin[J] Konrad Reinhart;Michael Meisner Critical Care Clinics 2011,

[6] Deaths: preliminary data for 2008.[J] Miniño Arialdi M;Xu Jiaquan;Kochanek Kenneth D National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System 2010,

[7] Sepsis biomarkers: a review.[J] Pierrakos Charalampos;Vincent Jean-Louis Critical care (London, England) 2010,

[8] Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis: a prospective study.[J] Brodska Helena;Drabek Tomas;Malickova Karin;Kazda Antonin;Vitek Antonin;Zima Tomas;Markova Marketa Critical care (London, England) 2009,

[9] Induction of procalcitonin in liver transplant patients treated with anti-thymocyte globulin.[J] Zazula Roman;Prucha Miroslav;Tyll Tomas;Kieslichova Eva Critical care (London, England) 2007,

[10] Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis[J] Benjamin MP Tang;Guy D Eslick;Jonathan C Craig;Anthony S McLean The Lancet Infectious Diseases 2007,